Related Experiment Video
Updated: Apr 21, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
1.2K
Intrathyroidal tumors presenting with extranodal extension: what are we missing?
Jason B Clain1, Saral Mehra, Sophie Scherl
1Thyroid Head and Neck Cancer Foundation, New York, NY, USA, jclain@thancfoundation.org.
Endocrine Pathology
|October 19, 2014
Summary
Histologic features of intrathyroidal well-differentiated thyroid cancer do not predict extranodal extension (ENE). Further molecular studies are needed to identify predictors of aggressive biology in these tumors.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Extranodal extension (ENE) is a poor prognostic indicator in well-differentiated thyroid cancer (WDTC).
- Extrathyroidal extension (ETE) predicts ENE in WDTC with positive lymph nodes, suggesting tumor biology concordance.
- The predictive value of primary tumor histology for ENE in intrathyroidal WDTC remains unclear.
Purpose of the Study:
- To investigate whether specific histologic features of primary intrathyroidal WDTC tumors predict lymph node ENE.
- To identify potential markers of aggressive tumor biology in early-stage WDTC.
Main Methods:
- Retrospective review of 39 patients with WDTC and positive lymph nodes (Jan 2004-Mar 2013).
- Compared histologic features (tumor size, capsule, infiltration, sclerosis, lymphocytic thyroiditis, psammoma bodies, LVI, PNI, architecture, focality) between ETE-negative/ENE-positive (n=12) and ETE-negative/ENE-negative (n=27) intrathyroidal tumors.
- Statistical analysis using Mann-Whitney and Fischer exact tests.
Main Results:
- No statistically significant differences were found in tumor size or the nine other examined histologic features between the ENE-positive and ENE-negative groups.
- Features like tumor size (p=0.072), encapsulation, infiltration, sclerosis, lymphocytic thyroiditis, psammoma bodies, lymphovascular invasion, perineural invasion, architecture, and focality did not significantly predict ENE.
- None of the evaluated histologic features reliably predicted extranodal extension in intrathyroidal WDTC.
Conclusions:
- Histologic examination of primary intrathyroidal WDTC tumors does not currently identify those with a higher risk of extranodal extension.
- Molecular analysis of intrathyroidal tumors is necessary to uncover features that predict ENE and aggressive behavior.
- Further research is needed to understand the molecular underpinnings of aggressive WDTC phenotypes.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
8
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
8
Hyperthyroidism I: Introduction
7
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
7
Goiter
3
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
3
Graves Disease II: Pathophysiology
8
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
8
Graves' Disease I: Introduction
7
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
7
The Thyroid Gland
6.8K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.8K

